<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="48" height="12" font="1">Sep 6, 2012</text>
<text top="347" left="94" width="446" height="12" font="1">Rabbit polyclonal, raised against KLH-conjugated, synthetic peptide corresponding to amino acids 659-675 </text>
<text top="359" left="94" width="429" height="12" font="1">(C-TNQPKQNQPTAIIQVED) of human CCCTC-binding factor (CTCF) with a N-terminal cysteine added for </text>
<text top="371" left="94" width="93" height="12" font="1">conjugation purposes.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="49" height="12" font="1">Dr. Flo Pauli</text>
<text top="215" left="121" width="24" height="12" font="1">CTCF </text>
<text top="215" left="339" width="339" height="12" font="1">synthetic peptide corresponding to amino acids 659-675 of CTCF of human origin</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="37" height="12" font="1">Millipore</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="2" height="12" font="1"> </text>
<text top="300" left="215" width="29" height="12" font="1">07-729</text>
<text top="521" left="395" width="73" height="12" font="2">Motif Enrichment</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="413" left="94" width="452" height="12" font="1">Chromatin binding factor that binds to DNA sequence specific sites. Involved in transcriptional regulation by </text>
<text top="425" left="94" width="441" height="12" font="1">binding to chromatin insulators and preventing interaction between promoter and nearby enhancers and </text>
<text top="437" left="94" width="40" height="12" font="1">silencers. </text>
<text top="449" left="94" width="114" height="12" font="1">Entrez gene: 10664. 83 kDa.</text>
<text top="599" left="238" width="157" height="12" font="1">http://www.millipore.com/catalogue/</text>
<text top="611" left="238" width="51" height="12" font="1">item/07-729</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="86" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="98" left="125" width="421" height="12" font="1">Whole cell lysates were immunoprecipitated using primary antibody (07-729), and the IP fraction was </text>
<text top="110" left="125" width="421" height="12" font="1">loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, </text>
<text top="122" left="125" width="419" height="12" font="1">the samples were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting </text>
<text top="134" left="125" width="431" height="12" font="1">with primary (same as that used for IP) and secondary HRP-conjugated antibodies was performed on an </text>
<text top="146" left="125" width="422" height="12" font="1">Invitrogen BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution </text>
<text top="158" left="125" width="84" height="12" font="1">(Thermo Scientific).  </text>
<text top="170" left="125" width="2" height="12" font="1"> </text>
<text top="182" left="125" width="344" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane. </text>
<text top="194" left="125" width="2" height="12" font="1"> </text>
<text top="206" left="125" width="397" height="12" font="1">Figure legend: IP-western with 07-729 in WCL (whole cell lysates) of SK-N-SH, HepG2, and K562; </text>
<text top="218" left="125" width="283" height="12" font="1">PM=protein marker. CTCF band is indicated, as is heavy chain of IgG.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="105" left="130" width="158" height="12" font="1">Motif enrichment validation protocol: </text>
<text top="117" left="130" width="419" height="12" font="1">Motif enrichment validation was performed by Pouya Kheradpour. Methods and results are available </text>
<text top="129" left="130" width="265" height="12" font="1">at http://www.broadinstitute.org/~pouyak/encode-motif-disc/. </text>
<text top="141" left="130" width="2" height="12" font="1"> </text>
<text top="153" left="130" width="407" height="12" font="1">Briefly, motif identification was performed on 100 bp peaks (50 bp on either side of peak summit), </text>
<text top="165" left="130" width="420" height="12" font="1">passing IDR between replicate experiments at &lt; .01. Identified motifs were matched to known motifs </text>
<text top="177" left="130" width="415" height="12" font="1">for the tested TF (correlation &gt; .75). ENCODE standards call for &gt; 4-fold enrichment and &gt; 10% motif </text>
<text top="189" left="130" width="395" height="12" font="1">representation in order to consider the identified motif validated. These standards are met and </text>
<text top="201" left="130" width="410" height="12" font="1">represented in the attached file, which includes cell line tested, name of maximally enriched motif, </text>
<text top="213" left="130" width="423" height="12" font="1">fold-enrichment value (as log2), and representation percentage. Additionally, known motif consensus </text>
<text top="225" left="130" width="264" height="12" font="1">sequences which were confirmed experimentally are displayed.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
